As with randomization, if allocation to the study drug is not carried out in accordance with the protocol, the entire study ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these ...

The peptide synthesis market is expanding due to growing demand for peptide-based therapeutics, driven by superior target specificity and lower toxicity. Innovations like microwave-assisted SPPS ...

In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

The global Process Analytical Technology (PAT) market is experiencing rapid expansion, driven by the pharmaceutical ...

MALMÖ, SE / ACCESS Newswire / February 5, 2026 / Ascelia Pharma AB (publ) (ticker:ACE)(STO:ACE) today published its Full Year and Q4 Report for 2025 (January - December), which is now available on the ...

This study is the first to provide evidence towards successful implementation and effectiveness of a Birthing on Country service and the wrap around care in a rural setting and supports the urgent ...

Despite dozens of lethal U.S. military strikes on suspected narco-boats, drug flows continue, allies are alarmed, and Caribbean fishermen say... U.S. strikes on alleged drug boats have done little to ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

FDA’s focus on playing a direct role in lowering drug prices may provide opportunities for some pharmaceutical companies to seek a regulatory advantage. But it also places enormous pressure on ...

Eduardo Gamarra does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...